These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Medical therapy of malignant melanoma]. Mini E; Periti P Ann Ital Chir; 1989; 60(4):257-63. PubMed ID: 2699710 [No Abstract] [Full Text] [Related]
4. Revolutionary Advances in Immunotherapy for Melanoma Are Coming into the Surgical Arena: Are We Ready? Balch CM Ann Surg Oncol; 2018 Jul; 25(7):1803-1806. PubMed ID: 29752603 [No Abstract] [Full Text] [Related]
5. Cellular vaccine therapies for cancer. Mastrangelo MJ; Sato T; Lattime EC; Maguire HC; Berd D Cancer Treat Res; 1998; 94():35-50. PubMed ID: 9587681 [No Abstract] [Full Text] [Related]
6. Immunotherapy as an adjuvant therapy in the management of advanced, surgically resected, melanoma. Kalani AD; Jack A; Montenegro G; Degliuomini J; Wallack MK G Ital Dermatol Venereol; 2008 Feb; 143(1):59-70. PubMed ID: 18833052 [TBL] [Abstract][Full Text] [Related]
12. Vaccine therapy for malignant melanoma. Morton DL; Barth A CA Cancer J Clin; 1996; 46(4):225-44. PubMed ID: 8673695 [No Abstract] [Full Text] [Related]
13. [Malignant melanoma and its treatment]. Luther U; Dichmann S; Norgauer J Med Monatsschr Pharm; 2001 Nov; 24(11):356-61. PubMed ID: 11727297 [No Abstract] [Full Text] [Related]
14. [Question of the month. Should treatment of Dubreuilh's melanoma be carcinologic?]. Ann Dermatol Venereol; 1993; 120(6-7):506-8. PubMed ID: 8279802 [No Abstract] [Full Text] [Related]
15. Possible role of adjuvant therapy for thin malignant melanoma. Lewis GL; Tyring SK; Wagner RF Cutis; 1992 Nov; 50(5):377-9. PubMed ID: 1468260 [TBL] [Abstract][Full Text] [Related]